Medical Research News

RSS

Seres Health closes $10 million Series B financing, signs research collaboration with Mayo Clinic

Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has closed its $10 million Series B financing that included existing investors Flagship Ventures and Enso Ventures, and included new investors, Mayo Clinic, Alexandria Venture Investments, and several private investors. The company has also entered into an exclusive research collaboration with the Mayo Clinic.

9 Jun 2014

Researchers tap rhythm of memories as they occur in real time in human brain

University of Oregon researchers have tapped the rhythm of memories as they occur in near real time in the human brain.

9 Jun 2014

Anthrax, brucellosis and bovine TB fail to receive official recognition, say researchers

Decades of neglect have allowed infectious diseases to devastate the lives of thousands of people in the developing world, a study reveals.

9 Jun 2014

Virtual reality can be effective adjunct for chronic and acute pain conditions

Chronic pain due to disease or injury is common, and even prescription pain medications cannot provide acceptable pain relief for many individuals.

9 Jun 2014

Protein-kinase interactions offer a new way to fight antimalarial drug resistance

When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and control the disease must be found.

9 Jun 2014

Tough driving laws reduce speeding-related fatalities among young men, shows study

A new study out of Western University (London, Canada) has found a significant decline in speeding-related fatalities and injuries among young men in Ontario since the province's tough extreme speeding and aggressive driving laws were introduced in 2007.

9 Jun 2014

NIDA review offers new insights into the negative health effects of marijuana

The current state of science on the adverse health effects of marijuana use links the drug to several significant adverse effects including addiction, a review reports.

9 Jun 2014

University of Indianapolis breaks ground June 19 on $28 million Health Pavilion

The University of Indianapolis will break ground June 19 on a four-story, $28 million Health Pavilion that will house UIndy's healthcare- and wellness-related academic programs as well as industry partners and clinical facilities to serve the community.

9 Jun 2014

Scientific images of blood, brain, bacteria are on display at Washington Dulles International Airport

Stunning scientific images of blood, brain, bacteria, viruses and more, enlarged by as much as 50,000 times, are on display in an exhibit called "Life: Magnified," on view through November 2014 at Washington Dulles International Airport's Gateway Gallery.

9 Jun 2014

Merck enters into definitive agreement with Idenix

Merck, known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc., today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.

9 Jun 2014

Rubicon signs agreements with 7 distributors to expand availability of DNA library preparation products

Rubicon Genomics, Inc., today announced that it signed agreements with seven distributors in Europe to expand the availability of its leading DNA library preparation products, including ThruPLEX®-FD Prep Kit and PicoPLEX™ DNA-seq Kit for use with Illumina® next-generation sequencing (NGS) systems and PicoPLEX™ WGA Kit for use on arrays, and to prepare for new product launches planned for the coming months.

9 Jun 2014

National Institutes of Health awards $3.4M grant for Alzheimer's disease research

As part of its ongoing research to better understand the complexities of the human brain, the Allen Institute for Brain Science is embarking on the first effort to map connectivity patterns across the whole brain in mouse models of Alzheimer's disease, through its recent award of a $3.4 million grant over five years from the National Institute on Aging of the National Institutes of Health.

9 Jun 2014

Certain molecules in seminal fluid indicate presence and severity of prostate cancer

Improved diagnosis and management of one of the most common cancers in men - prostate cancer - could result from research at the research at the University of Adelaide, which has discovered that seminal fluid (semen) contains biomarkers for the disease.

9 Jun 2014

Mylan launches generic version of Bristol-Myers Squibb's Paraplatin Injection

Mylan Inc. today announced that it has launched Carboplatin Injection, 50 mg/5 ml, in multi-dose vials, which is the generic version of Bristol-Myers Squibb's Paraplatin® Injection.

9 Jun 2014

Researchers identify critical weakness of invasive cancer cells

Metastatic cancer cells, which can migrate from primary tumors to seed new malignancies, have thus far been resistant to the current arsenal of anticancer drugs.

9 Jun 2014

Research finding paves way for targeted approaches to treating cancer patients

Twelve years ago, UNC School of Medicine researcher Brian Strahl, PhD, found that a protein called Set2 plays a role in how yeast genes are expressed - specifically how DNA gets transcribed into messenger RNA. Now his lab has found that Set2 is also a major player in DNA repair, a complicated and crucial process that can lead to the development of cancer cells if the repair goes wrong.

9 Jun 2014

Studies stress the importance of vitamin D intake during first year of life

Everyone seems to agree that vitamin D is important throughout life. This is certainly as true in the first year of life as it is later on.

9 Jun 2014

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI).

9 Jun 2014

Accelera signs agreement to complete preclinical studies of Cellectis' UCART19

Cellectis, a leader of allogeneic CAR T-cell therapies, and Accelera, the preclinical CRO (Contract Research Organisation) within the Nerviano Medical Sciences Group, recently signed an agreement to complete the preclinical studies of Cellectis' advanced product candidate, UCART19.

9 Jun 2014

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.

9 Jun 2014

Medical Research News

Seres Health closes $10 million Series B financing, signs research collaboration with Mayo Clinic

Researchers tap rhythm of memories as they occur in real time in human brain

Anthrax, brucellosis and bovine TB fail to receive official recognition, say researchers

Virtual reality can be effective adjunct for chronic and acute pain conditions

Protein-kinase interactions offer a new way to fight antimalarial drug resistance

Tough driving laws reduce speeding-related fatalities among young men, shows study

NIDA review offers new insights into the negative health effects of marijuana

University of Indianapolis breaks ground June 19 on $28 million Health Pavilion

Scientific images of blood, brain, bacteria are on display at Washington Dulles International Airport

Merck enters into definitive agreement with Idenix

Rubicon signs agreements with 7 distributors to expand availability of DNA library preparation products

National Institutes of Health awards $3.4M grant for Alzheimer's disease research

Certain molecules in seminal fluid indicate presence and severity of prostate cancer

Mylan launches generic version of Bristol-Myers Squibb's Paraplatin Injection

Researchers identify critical weakness of invasive cancer cells

Research finding paves way for targeted approaches to treating cancer patients

Studies stress the importance of vitamin D intake during first year of life

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Accelera signs agreement to complete preclinical studies of Cellectis' UCART19

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News